Overview of animal researches about the effects of systemic drugs on implant osseointegration

doi:10.7518/hxkq.2020.02.017

Abstract

Abstract:

Implant osseointegration is an important biological basis for dental implantology. Many factors, including surgical factors, implant factors, and patients’ own factors, affect implant osseointegration. Notably, the application of systemic drugs to improve implant osseointegration has become a research hotspot. This article reviews the effects of systemic drugs on implant osseointegration based on animal researches to provide systemic drug selection to improve implant osseointegration and lay a good foundation for later clinical trials.

Key words: implant, osseointegration, systemic drugs, animal researches

CLC Number:

R783

Wang Ya’nan, Jia Tingting, Xu Xin, Zhang Dongjiao. Overview of animal researches about the effects of systemic drugs on implant osseointegration[J]. West China Journal of Stomatology, 2020, 38(2): 211-217.

References 74

[1]	张志愿 . 口腔颌面外科学[M]. 北京：人民卫生出版社, 2012: 152-153.
	Zhang ZY . Oral and maxillofacial surgery[M]. Beijing：People’s Medical Publishing House, 2012: 152-153.
[2]	Fan Y, Hanai JI, Le PT , et al. Parathyroid hormone directs bone marrow mesenchymal cell fate[J]. Cell Metab, 2017,25(3):661-672.
[3]	Silva BC, Bilezikian JP . Parathyroid hormone: anabolic and catabolic actions on the skeleton[J]. Curr Opin Pharmacol, 2015,22:41-50.
[4]	Brouwers JE, van Rietbergen B, Huiskes R , et al. Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT[J]. Osteoporos Int, 2009,20(11):1823-1835.
[5]	Yang X, Ricciardi BF, Dvorzhinskiy A , et al. Intermittent parathyroid hormone enhances cancellous osseointegration of a novel murine tibial implant[J]. J Bone Joint Surg Am, 2015,97(13):1074-1083.
[6]	Dayer R, Badoud I, Rizzoli R , et al. Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate[J]. J Bone Miner Res, 2007,22(10):1526-1533.
[7]	Jiang L, Zhang W, Wei L , et al. Early effects of parathyroid hormone on vascularized bone regeneration and implant osseointegration in aged rats[J]. Biomaterials, 2018,179:15-28.
[8]	Almagro MI, Roman-Blas JA, Bellido M , et al. PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis[J]. Clin Oral Implants Res, 2013,24(9):1027-1034.
[9]	Tao ZS, Zhou WS, Tu KK , et al. The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats[J]. Injury, 2015,46(11):2164-2169.
[10]	Rybaczek T, Tangl S, Dobsak T , et al. The effect of parathyroid hormone on osseointegration in insulin-treated diabetic rats[J]. Implant Dent, 2015,24(4):392-396.
[11]	Neer RM, Arnaud CD, Zanchetta JR , et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis[J]. New Eng J Med, 2001,344(19):1434-1441.
[12]	Miller PD . Safety of parathyroid hormone for the treatment of osteoporosis[J]. Curr Osteoporos Rep, 2008,6(1):12-16.
[13]	van de Peppel J, van Leeuwen JP . Vitamin D and gene networks in human osteoblasts[J]. Front Physiol, 2014,5:137.
[14]	Fretwurst T, Grunert S, Woelber JP , et al. Vitamin D deficiency in early implant failure: two case reports[J]. Int J Implant Dent, 2016,2(1):24.
[15]	Nakamura Y, Hayashi K, Abu-Ali S , et al. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats[J]. J Bone Joint Surg Am, 2008,90(4):824-832.
[16]	Bikle DD . Vitamin D metabolism, mechanism of action, and clinical applications[J]. Chem Biol, 2014,21(3):319-329.
[17]	Zhou C, Li Y, Wang X , et al. 1,25Dihydroxy vitamin D(3) improves titanium implant osseointegration in osteoporotic rats[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012,114(5 Suppl):S174-S178.
[18]	Vieth R . Vitamin D toxicity, policy, and science[J]. J Bone Miner Res, 2007,22(Suppl 2):V64-V68.
[19]	Young RN, Grynpas MD . Targeting therapeutics to bone by conjugation with bisphosphonates[J]. Curr Opin Pharmacol, 2018,40:87-94.
[20]	Onishi E, Fujibayashi S, Takemoto M , et al. Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist[J]. Biomaterials, 2008,29(7):877-883.
[21]	Hayashi K, Fotovati A, Ali SA , et al. Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis[J]. J Bone Joint Surg Br, 2005,87(8):1150-1156.
[22]	Masuzawa M, Beppu M, Ishii S , et al. Experimental study of bone formation around a titanium rod with β- tricalcium phosphate and prostaglandin E2 receptor agonists[J]. J Orthopaed Sci, 2005,10(3):308-314.
[23]	Olivares-Navarrete R, Hyzy S, Wieland M , et al. The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces[J]. Biomaterials, 2010,31(8):2015-2024.
[24]	Li X, Grisanti M, Fan W , et al. Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury[J]. J Bone Miner Res, 2011,26(11):2610-2621.
[25]	Agholme F, Isaksson H, Kuhstoss S , et al. The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions[J]. Bone, 2011,48(5):988-996.
[26]	McClung MR, Grauer A, Boonen S , et al. Romosozumab in postmenopausal women with low bone mineral density[J]. N Engl J Med, 2014,370(5):412-420.
[27]	Virdi AS, Liu M, Sena K , et al. Sclerostin antibody increases bone volume and enhances implant fixation in a rat model[J]. J Bone Joint Surg Am, 2012,94(18):1670-1680.
[28]	Yu SH, Hao J, Fretwurst T , et al. Sclerostin-neutralizing antibody enhances bone regeneration around oral implants[J]. Tissue Eng Part A, 2018,24(21/22):1672-1679.
[29]	Virdi AS, Irish J, Sena K , et al. Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis[J]. J Bone Joint Surg Am, 2015,97(2):133-140.
[30]	Nakamichi M, Akishima-Fukasawa Y, Fujisawa C , et al. Basic fibroblast growth factor induces angiogenic properties of fibrocytes to stimulate vascular formation during wound healing[J]. Am J Pathol, 2016,186(12):3203-3216.
[31]	Gronowicz G, Hurley MM, Kuhn LT . Optimizing BMP-2-induced bone repair with FGF-2[J]. J Am Acad Orthop Surg, 2014,22(10):677-679.
[32]	Nagayasu-Tanaka T, Nozaki T, Miki K , et al. FGF-2 promotes initial osseointegration and enhances stability of implants with low primary stability[J]. Clin Oral Implants Res, 2017,28(3):291-297.
[33]	Gao Y, Luo E, Hu J , et al. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats[J]. Bone, 2009,44(2):225-232.
[34]	Guang M, Yao Y, Zhang L , et al. The effects of nerve growth factor on endothelial cells seeded on different titanium surfaces[J]. Int J Oral Maxillofac Surg, 2015,44(12):1506-1513.
[35]	姚洋, 杜宇, 古霞 , 等. 局部注射外源性神经生长因子促进小鼠钛种植体周骨胶原早期成熟的研究[J]. 华西口腔医学杂志, 2018,36(2):128-132.
	Yao Y, Du Y, Gu X , et al. Local injection of exogenous nerve growth factor improves early bone maturation of implants[J]. West China J Stomatol, 2018,36(2):128-132.
[36]	Zhang J, Shirai M, Yamamoto R , et al. Effect of nerve growth factor on osseointegration of titanium implants in type 2 diabetic rats[J]. Int J Oral Maxillofac Implants, 2016,31(5):1189-1194.
[37]	Sexton PM, Findlay DM, Martin TJ . Calcitonin[J]. Curr Med Chem, 1999,6(11):1067-1093.
[38]	Wimalawansa SJ . Long- and short-term side effects and safety of calcitonin in man: a prospective study[J]. Calcif Tissue Int, 1993,52(2):90-93.
[39]	Huang L, Luo Z, Hu Y , et al. Enhancement of local bone remodeling in osteoporotic rabbits by biomimic multilayered structures on Ti6Al4V implants[J]. J Biomed Mater Res A, 2016,104(6):1437-1451.
[40]	Nociti FH Jr, Sallum AW, Sallum EA , et al. Effect of estrogen replacement and calcitonin therapies on bone around titanium implants placed in ovariectomized rats: a histometric study[J]. Int J Oral Maxillofac Implants, 2002,17(6):786-792.
[41]	Duarte PM, de Vasconcelos Gurgel BC, Sallum AW , et al. Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats[J]. J Periodontol, 2005,76(1):107-114.
[42]	Verzola MH, Frizzera F, de Oliveira GJ , et al. Effects of the long-term administration of alendronate on the mechanical properties of the basal bone and on osseointegration[J]. Clin Oral Implants Res, 2015,26(12):1466-1475.
[43]	Oh KC, Hwang W, Park YB , et al. Effects of alendronate on bone remodeling around osseointegrated implants in rats[J]. Implant Dent, 2017,26(1):46-53.
[44]	Jensen TB, Bechtold JE, Chen X , et al. Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants[J]. J Orthop Res, 2007,25(6):772-778.
[45]	Chacon GE, Stine EA, Larsen PE , et al. Effect of alendronate on endosseous implant integration: an in vivo study in rabbits[J]. J Oral Maxillofac Surg, 2006,64(7):1005-1009.
[46]	Karlsson J, Martinelli A, Fathali HM , et al. The effect of alendronate on biomineralization at the bone/implant interface[J]. J Biomed Mater Res A, 2016,104(3):620-629.
[47]	Skoglund B, Holmertz J, Aspenberg P . Systemic and local ibandronate enhance screw fixation[J]. J Orthop Res, 2004,22(5):1108-1113.
[48]	Kurth AH, Eberhardt C, Muller S , et al. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats[J]. Bone, 2005,37(2):204-210.
[49]	Eberhardt C, Schwarz M, Kurth AH . High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implants[J]. J Orthop Sci, 2005,10(6):622-626.
[50]	Kellesarian SV, Abduljabbar T, Vohra F , et al. Does local ibandronate and/or pamidronate delivery enhance osseointegration? a systematic review[J]. J Prosthodont, 2018,27(3):240-249.
[51]	Dikicier E, Karacayli U, Dikicier S , et al. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats[J]. J Craniomaxillofac Surg, 2014,42(7):1106-1111.
[52]	Li JP, Li P, Hu J , et al. Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits[J]. J Periodontol, 2014,85(2):308-316.
[53]	Kim I, Ki H, Lee W , et al. The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in the rabbit maxilla[J]. Int J Oral Maxillofac Implants, 2013,28(5):1194-1200.
[54]	Tella SH, Gallagher JC . Prevention and treatment of postmenopausal osteoporosis[J]. J Steroid Biochem Mol Biol, 2014,142:155-170.
[55]	Khosla S, Burr D, Cauley J , et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the american society for bone and mineral research[J]. J Bone Miner Res, 2007,22(10):1479-1491.
[56]	Liu Y, Hu J, Liu B , et al. The effect of osteoprotegerin on implant osseointegration in ovariectomized rats[J]. Arch Med Sci, 2017,13(2):489-495.
[57]	Aspenberg P, Agholme F, Magnusson P , et al. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening[J]. Bone, 2011,48(2):225-230.
[58]	Bernhardsson M, Sandberg O, Aspenberg P . Anti-RANKL treatment improves screw fixation in cancellous bone in rats[J]. Injury, 2015,46(6):990-995.
[59]	Sköldenberg O, Rysinska A, Eisler T , et al. Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial[J]. BMC Musculoskelet Disord, 2016,17:174.
[60]	Faverani LP, Polo TOB, Ramalho-Ferreira G , et al. Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats[J]. Clin Oral Investig, 2018,22(1):255-265.
[61]	Mu C, Hu Y, Huang L , et al. Sustained raloxifene release from hyaluronan-alendronate-functionalized titanium nanotube arrays capable of enhancing osseointegration in osteoporotic rabbits[J]. Mater Sci Eng C Mater Biol Appl, 2018,82:345-353.
[62]	Maximov PY, Lee TM, Jordan VC . The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice[J]. Curr Clin Pharmacol, 2013,8(2):135-155.
[63]	Mundy G, Garrett R, Harris S , et al. Stimulation of bone formation in vitro and in rodents by statins[J]. Science, 1999,286(5446):1946-1949.
[64]	Staal A, Frith JC, French MH , et al. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity[J]. J Bone Miner Res, 2003,18(1):88-96.
[65]	Ayukawa Y, Okamura A, Koyano K . Simvastatin promotes osteogenesis around titanium implants[J]. Clin Oral Implants Res, 2004,15(3):346-350.
[66]	Ayukawa Y, Ogino Y, Moriyama Y , et al. Simvastatin enhances bone formation around titanium implants in rat tibiae[J]. J Oral Rehabil, 2010,37(2):123-130.
[67]	Du Z, Chen J, Yan F , et al. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats[J]. Clin Oral Implants Res, 2009,20(2):145-150.
[68]	Kwon YD, Yang DH, Lee DW . A titanium surface-modified with nano-sized hydroxyapatite and simvastatin enhances bone formation and osseintegration[J]. J Biomed Nanotechnol, 2015,11(6):1007-1015.
[69]	Scott RS, Lintott CJ, Wilson MJ . Simvastatin and side effects[J]. New Zealand Med J, 1991,104(924):493.
[70]	Marie PJ . Strontium ranelate: a physiological approach for optimizing bone formation and resorption[J]. Bone, 2006,38(2 Suppl 1):S10-S14.
[71]	Tao ZS, Zhou WS, He XW , et al. A comparative study of zinc, magnesium, strontium-incorporated hydroxyapatite-coated titanium implants for osseointegration of osteopenic rats[J]. Mater Sci Eng C Mater Biol Appl, 2016,62:226-232.
[72]	Li Y, Feng G, Gao Y , et al. Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats[J]. J Orthop Res, 2010,28(5):578-582.
[73]	Linderback P, Agholme F, Wermelin K , et al. Weak effect of strontium on early implant fixation in rat tibia[J]. Bone, 2012,50(1):350-356.
[74]	O’Donnell S, Cranney A, Wells GA , et al. Strontium ranelate for preventing and treating postmenopausal osteoporosis [J]. Cochrane Database Syst Rev, 2006, 19(3)CD005326.